← Back to headlines
Israeli-Founded AI Biotech Immunai Collaborates with Boehringer Ingelheim
Israeli-founded AI biotech company Immunai has launched a drug-discovery collaboration with Boehringer Ingelheim, utilizing Immunai’s single-cell AI platform to identify T-cell targets in cancer and autoimmune diseases.
25 Jun, 16:01 — 25 Jun, 16:01
Related Stories
Norwegian Royal Family and Public Gather for Memorial Service of Late King Harald
19m ago
Police Officer Killed and Another Wounded in South Carolina Park Shooting
21m ago
CIA Chief Proposes Trilateral Summit for Trump, Putin, and Zelenskyy
22m ago
Death Toll from Devastating Nepal and China Floods Reaches 750
23m ago